ConductScience.org, home

Paper39735441

Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges.

Liu Z and 4 others. J Natl Cancer Cent, 2024. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges. Papers, record 39735441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39735441

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges.
PubMed
Journal
J Natl Cancer Cent
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
4.52, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu ZZongchao
2Xu HHengmin
3You WWeicheng
4Pan KKaifeng
5Li WWenqing

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References165

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114722144Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.JAMA2004https://conductscience.org/library/papers/14722144PubMed
237009691Cancer Progress and Priorities: Gastric Cancer.Cancer Epidemiol Biomarkers Prev2023https://conductscience.org/library/papers/37009691PubMed
339079993Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial.Nat Med2024https://conductscience.org/library/papers/39079993PubMed
436069529Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study.Cancer Biol Med2022https://conductscience.org/library/papers/36069529PubMed
517167474Inflammation and metabolic disorders.Nature2006https://conductscience.org/library/papers/17167474PubMed
637178702
Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials.
Lancet Gastroenterol Hepatol2023https://conductscience.org/library/papers/37178702PubMed
736789941Allium vegetable intake associated with the risk of incident gastric cancer: a continuous follow-up study of a randomized intervention trial.Am J Clin Nutr2023https://conductscience.org/library/papers/36789941PubMed
830311721Gut microbiome can be restored without adverse events after Helicobacter pylori eradication therapy in teenagers.Helicobacter2018https://conductscience.org/library/papers/30311721PubMed
911171812Blood, urine, stool, breath, money, and Helicobacter pylori.Gut2001https://conductscience.org/library/papers/11171812PubMed
1010382128Randomized placebo-controlled trial of Helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents.Helicobacter1999https://conductscience.org/library/papers/10382128PubMed
1116849680Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.J Natl Cancer Inst2006https://conductscience.org/library/papers/16849680PubMed
1229559361Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.Clin Gastroenterol Hepatol2018https://conductscience.org/library/papers/29559361PubMed
1330145102The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial.EBioMedicine2018https://conductscience.org/library/papers/30145102PubMed
1411018097Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors.J Natl Cancer Inst2000https://conductscience.org/library/papers/11018097PubMed
1534645495Impact of Helicobacter pylori eradication on the gastric microbiome.Gut Pathog2021https://conductscience.org/library/papers/34645495PubMed
1631673902Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model.Dig Dis Sci2020https://conductscience.org/library/papers/31673902PubMed
1738572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1829990487Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions.Gastroenterology2018https://conductscience.org/library/papers/29990487PubMed
1932285569
Helicobacter pylori "Test-and-Treat" strategy with urea breath test: A cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative.
Helicobacter2020https://conductscience.org/library/papers/32285569PubMed
2021188333Worldwide H. pylori antibiotic resistance: a systematic review.J Gastrointestin Liver Dis2010https://conductscience.org/library/papers/21188333PubMed

See all 165 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42959320Global burden, trends, and projections of five major upper gastrointestinal diseases, 1990-2046: an analysis of GBD 2021.Front Public Health2026https://conductscience.org/library/papers/42959320PubMed
42891186Genetically determined heterogeneous treatment effects of Helicobacter pylori eradication for targeted gastric cancer prevention.Innovation (Camb)2026https://conductscience.org/library/papers/42891186PubMed
42585493VTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION.Arq Gastroenterol2026https://conductscience.org/library/papers/42585493PubMed
42446197Genetic susceptibility, environmental risk factors, and incident gastric cancer risk among individuals with different Helicobacter pylori infection status: a population-based study.Cancer Biol Med2026https://conductscience.org/library/papers/42446197PubMed
42305456The research progress of gastric cancer vaccines: a narrative review.Transl Cancer Res2026https://conductscience.org/library/papers/42305456PubMed
42032685LncRNA LINC01579/miR-579-3p axis promotes gastric cancer progression via NOTCH1 pathway.World J Surg Oncol2026https://conductscience.org/library/papers/42032685PubMed
41923851Investigating the Devil's tree(Alstonia scholaris) for its health-safeguardingproperty and antipathogenic activities against fungi and helminthparasites of veterinary importance.J Adv Vet Anim Res2025https://conductscience.org/library/papers/41923851PubMed
41531650Helicobacter pylori and Cancer: What's the Link?Clin Exp Gastroenterol2026https://conductscience.org/library/papers/41531650PubMed
41415806Therapeutic advances and future directions in Helicobacter pylori eradication.Front Microbiol2025https://conductscience.org/library/papers/41415806PubMed
41384272Concomitant Versus Tailored Therapy Based on Antibiotic Resistance Profiles for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis.JGH Open2025https://conductscience.org/library/papers/41384272PubMed
41189901Microbiome influence in gastric cancer progression and therapeutic strategies.Front Med (Lausanne)2025https://conductscience.org/library/papers/41189901PubMed
41103822Long-Term Proton Pump Inhibitor Therapy and Risk of Gastric Atrophy and Precancerous Mucosal Changes: A Systematic Review.Cureus2025https://conductscience.org/library/papers/41103822PubMed
40794596The global and regional burden of early-onset gastric cancer (15-49 years, 1990-2021): incidence and mortality with projections to 2030.Oncologist2025https://conductscience.org/library/papers/40794596PubMed
40284604Evaluation of the Rapid Urease Test (RUT) Device for Rapid Diagnosis of Helicobacter pylori in Middle-Aged and Elderly Taiwanese Patients.Microorganisms2025https://conductscience.org/library/papers/40284604PubMed
40252119Streptococcus anginosus: the potential role in the progression of gastric cancer.J Cancer Res Clin Oncol2025https://conductscience.org/library/papers/40252119PubMed
40242368Prevalence of HER2 expression and its association with clinicopathological parameters in gastric and gastroesophageal junction adenocarcinoma: A 10?year experience of an academic center.Mol Clin Oncol2025https://conductscience.org/library/papers/40242368PubMed
40242267Role of SMYD2 in gastrointestinal cancer progression (Review).Oncol Lett2025https://conductscience.org/library/papers/40242267PubMed
40231997Plasma L-aspartic acid predicts the risk of gastric cancer and modifies the primary prevention effect: a multistage metabolomic profiling and Mendelian randomization study.Cancer Biol Med2025https://conductscience.org/library/papers/40231997PubMed
39936539Large-scale cluster randomised trial reveals effectiveness of Helicobacter pylori eradication for gastric cancer prevention.Clin Transl Med2025https://conductscience.org/library/papers/39936539PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39735441

GET https://conductscience.org/api/papers/v1/39735441/references?page=2